Healthcare and Pharmaceuticals
Global HPV Testing & PAP Test Market was valued at USD XX billion in the year 2017. Global HPV Testing & PAP Test market is further estimated to grow at a CAGR of XX % from 2018 to reach USD XX billion by the year 2023.
In the Global HPV Testing & PAP Test Market, by region, North America holds the highest market share in 2017 and the Asia Pacific is also considered as the fastest growing market in the forecasted period owing to their market demands. At the country level, U.S China and India is projected to grow strongly in the coming years increased cases of cervical cancer and the growing awareness amongst women.
Increasing Awareness of Cervical Cancer Screening Programs
Changing government regulations and norms.
Government Initiatives and Funding
Uncertain Reimbursement Scenario
The segmentation is done on the basis of resin type, by Test type, by application, by end use, and by region. The Pap test segment is expected to account for the largest share of the HPV testing market in 2015. HPV testing segment is expected to grow at the highest CAGR of XX%.
On the basis of type of application, the global HPV testing market is classified into two major segments, namely, cervical cancer screening and vaginal cancer screening. The cervical cancer screening application segment is expected to account for the largest share of the Pap test market in 2017.
Abbott Laboratories (U.S.), Qiagen N.V. (The Netherlands), Hologic Inc. (U.S.), Roche Diagnostics (Switzerland), Quest Diagnostics (U.S.), Becton, Dickinson and Company (U.S.) are some of the key players in the Global HPV Testing & PAP Test market.
Key Benefits for Stakeholders
HPV Testing & Pap test products Manufacturers, Distributors, and Retailers
Healthcare and R&D institutions
Research and Consulting Organization
Investment research firms
By Test Type
Follow-up HPV Testing
HPV Primary testing
Cervical Cancer Screening
Vaginal Cancer Screening
By End Users
Ambulatory Care Centers
Key Market Players
Arbor Vita Corporation
Onco Health Corporation
Becton, Dickinson and Company
(A brief overview of 10 companies is also provided)
Genesis Market Insights follows in-depth Research Methodology focused on reducing deviation in the collected data. GMI offers the most precise evaluations and projection for the market numbers. GMI engages following Market Engineering techniques –
Detailed customization is also available for you. Further, if the report listed above does not meet your key requirements. Our customized research report will analytically cover the required market information you need which will help you to plan your business decisions.
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
2. Research Methodology
2.1. Research Process
2.1.1. Secondary Research
184.108.40.206. Key Data from Secondary Research
2.1.2. Primary Research
220.127.116.11. Key Data from Primary Research
18.104.22.168. Breakdowns of Primary Interviews
2.2. Market Size Estimation
2.2.1. Bottom-Up Approach
2.2.2. Top-Down Approach
2.2.3. Annual Revenue Process
2.3. Data Triangulation
2.4. Research Assumptions
3. Executive Summary
4. Market Overview
4.7. Supply Chain/Value Chain Analysis
4.8. Patent & Standards
5. Industry Trends
5.2. Porter’s Five Forces Analysis
5.2.1. Threat of New Entrants
5.2.2. Threat of Substitutes
5.2.3. Bargaining Power of Buyers
5.2.4. Bargaining Power of Suppliers
5.2.5. Intensity of Competitive Rivalry
6. HPV Testing & PAP Test Market, By Test Type
6.1 HPV Testing
6.2 Follow-up HPV Testing
6.4 HPV Primary testing
6.5 Pap Test
7. HPV Testing & PAP Test Market, By Application
7.1 Pap Test
7.2 Cervical Cancer Screening
7.3 Vaginal Cancer Screening
8. HPV Testing & Pap test Market, By End Users
8.2 Commercial Laboratories
8.3 Ambulatory Care Centers
8.4 Other settings
9. Geographical Analysis
9.2. North America
9.4. Asia Pacific
9.4.1. South Korea
9.5.1. Latin America
9.5.2. Middle East and Africa
10. Company Profiles
(Business Overview, Financial Overview, Product write Up, Recent Developments)
10.1 Arbor Vita Corporation
10.2 Femasys Inc.
10.3 Onco Health Corporation
10.4 Seegene, Inc.
10.5 Becton, Dickinson and Company
10.6 Quest Diagnostics
10.7 Abbott Laboratories
10.8 Hologic, Inc.
10.9 Qiagen N.V.
10.10 Roche Diagnostics
(A brief overview of 10 companies is also provided.)
11. Competitive Analysis
11.2. Market Positioning of Key Players
11.3 Competitive Strategies Adopted by Leading Players
11.3.1. Investments & Expansions
11.3.2. New Product Launches
11.3.3. Mergers & Acquisitions
11.3.4. Agreements, Joint Ventures, and Partnerships
12.2. Available Customizations
12.3. Upcoming Events (Trade Fair, Exhibitions, Conferences)
*The list of tables and figures will be provided in the sample report.
No Content Available.